Total Payments
$1,164
2024 Payments
$260.08
Companies
11
Transactions
13
Medicare Patients
1,963
Medicare Billing
$141,847
Payment Breakdown by Category
Food & Beverage$1,164 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,164 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $249.98 | 2 | $0 (2024) |
| Boston Scientific Corporation | $163.14 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $124.99 | 1 | $0 (2023) |
| Lilly USA, LLC | $124.99 | 1 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $124.99 | 1 | $0 (2021) |
| Genentech USA, Inc. | $102.40 | 1 | $0 (2021) |
| Eisai Inc. | $86.36 | 1 | $0 (2024) |
| Nevro Corp. | $84.51 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $69.07 | 1 | $0 (2022) |
| Novo Nordisk Inc | $19.58 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $260.08 | 4 | Otsuka America Pharmaceutical, Inc. ($124.99) |
| 2023 | $607.07 | 6 | Boston Scientific Corporation ($133.99) |
| 2022 | $69.07 | 1 | Janssen Pharmaceuticals, Inc ($69.07) |
| 2021 | $227.39 | 2 | Teva Pharmaceuticals USA, Inc. ($124.99) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $29.15 | General |
| 04/11/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $86.36 | General |
| Category: Neurology | ||||||
| 03/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
| 11/09/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $84.51 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/18/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $133.99 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/10/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Diabetes | ||||||
| 09/28/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
| 08/10/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RESPIRATORY | ||||||
| 06/08/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.60 | General |
| Category: PSYCHIATRY | ||||||
| 08/23/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $69.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/09/2021 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $102.40 | General |
| Category: Immunology | ||||||
| 11/04/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 29 | 31 | $8,171 | $1,348 |
| 2022 | 24 | 661 | 939 | $144,747 | $47,218 |
| 2021 | 26 | 757 | 1,001 | $148,052 | $49,576 |
| 2020 | 15 | 516 | 722 | $136,727 | $43,705 |
Total Patients
1,963
Total Services
2,693
Medicare Billing
$141,847
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 29 | 31 | $8,171 | $1,348 | 16.5% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2022 | 113 | 250 | $66,133 | $18,742 | 28.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 43 | 46 | $26,586 | $8,560 | 32.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 52 | 52 | $14,132 | $5,665 | 40.1% |
| 99350 | Established patient home visit, typically 1 hour | Office | 2022 | 29 | 36 | $13,279 | $4,086 | 30.8% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 18 | 20 | $8,585 | $2,565 | 29.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 20 | 20 | $2,610 | $1,371 | 52.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 35 | 57 | $1,526 | $753.72 | 49.4% |
| 99348 | Established patient home visit, typically 25 minutes | Office | 2022 | 13 | 13 | $2,230 | $710.03 | 31.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 30 | 39 | $1,310 | $647.04 | 49.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 20 | $1,229 | $602.20 | 49.0% |
| 82306 | Vitamin d-3 level | Office | 2022 | 19 | 20 | $1,184 | $585.18 | 49.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 42 | 69 | $1,072 | $529.09 | 49.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 37 | 49 | $1,035 | $510.76 | 49.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 20 | 23 | $693.68 | $342.04 | 49.3% |
| 82746 | Folic acid level, serum | Office | 2022 | 20 | 23 | $676.20 | $333.43 | 49.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 19 | 23 | $446.66 | $220.36 | 49.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 42 | 69 | $414.00 | $204.66 | 49.4% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 12 | 13 | $354.38 | $175.28 | 49.5% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 16 | 17 | $306.68 | $151.36 | 49.4% |
| 83550 | Iron binding capacity | Office | 2022 | 12 | 13 | $227.24 | $112.41 | 49.5% |
| 83735 | Magnesium level | Office | 2022 | 11 | 15 | $201.00 | $99.25 | 49.4% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2022 | 13 | 15 | $195.30 | $96.39 | 49.4% |
| 83540 | Iron level | Office | 2022 | 12 | 13 | $168.22 | $83.22 | 49.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 13 | 24 | $152.16 | $72.94 | 47.9% |
About Laura Sieben, ARNP
Laura Sieben, ARNP is a Family healthcare provider based in North Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2018. The National Provider Identifier (NPI) number assigned to this provider is 1316443732.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Laura Sieben, ARNP has received a total of $1,164 in payments from pharmaceutical and medical device companies, with $260.08 received in 2024. These payments were reported across 13 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,164).
As a Medicare-enrolled provider, Sieben has provided services to 1,963 Medicare beneficiaries, totaling 2,693 services with total Medicare billing of $141,847. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location North Fort Myers, FL
- Active Since 04/04/2018
- Last Updated 06/16/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1316443732
Products in Payments
- REXULTI (Drug) $263.58
- WATCHMAN FLX (Device) $133.99
- AREXVY (Drug) $124.99
- AUSTEDO (Drug) $124.99
- MOUNJARO (Drug) $124.99
- Xolair (Biological) $102.40
- Leqembi (Drug) $86.36
- Senza (Device) $84.51
- XARELTO (Drug) $69.07
- Ozempic (Drug) $19.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.